Cocrystal Pharma (COCP) Other Operating Expenses (2010 - 2023)

Cocrystal Pharma (COCP) has 9 years of Other Operating Expenses data on file, last reported at -$1.0 million in Q4 2023.

• For the quarter ending Q4 2023, Other Operating Expenses changed N/A year-over-year to -$1.0 million; the trailing twelve-month figure through Sep 2024 stood at -$1.0 million (up 37.5% YoY), and the FY2023 full-year result was -$2.6 million, down 112.57% from the prior year.
• Other Operating Expenses grew to -$1.0 million in Q4 2023, from -$1.6 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $46.1 million in Q4 2019 to a low of -$1.6 million in Q3 2023.
• A 3-year average of $16.0 million and a median of $9.8 million in 2022 frame the typical range for Other Operating Expenses.
• Peak annual rise in Other Operating Expenses reached 4610200.0% in 2019, while the deepest fall reached 4610200.0% in 2019.
• Tracing COCP's Other Operating Expenses over 3 years: stood at $46.1 million in 2019, then slumped by 55.12% to $20.7 million in 2022, then sank by 104.83% to -$1.0 million in 2023.
• Business Quant data shows COCP's Other Operating Expenses at -$1.0 million in Q4 2023, -$1.6 million in Q3 2023, and $20.7 million in Q2 2022.